ZELGOR TABLETS

Product Description

Abiraterone Acetate is the active component of the medicine Zelgor. Adult males with metastatic castration-resistant prostate cancer (mCRPC) are treated with it. An androgen biosynthesis inhibitor, such as abiraterone acetate, prevents the creation of androgens like testosterone, which feed the growth of prostate cancer cells. Zelgor pills are taken orally, and prednisone or prednisolone are frequently used with them. Fatigue, hypertension, and fluid retention are typical adverse effects. To reduce potential side effects and guarantee therapeutic effectiveness in individuals with mCRPC, regular medical monitoring is crucial during treatment.

Zelgor (tablets containing abiraterone acetate) uses:

1. Adult males with metastatic castration-resistant prostate cancer (mCRPC) are treated with Zelgor, which has abiraterone acetate as its active ingredient. Combining it with prednisone or prednisolone is recommended.

Zelgor (Abiraterone Acetate Tablets) side effects include:

Zelgor can have a number of adverse effects, and each person will likely experience them to varying degrees. Typical negative consequences could be: 

1. Abiraterone Acetate has the potential to cause hypertension (high blood pressure).

2. Fluid Retention: Some people may swell as a result of fluid retention.

3. Abiraterone Acetate may result in decreased potassium levels in the blood, which is known as hypokalemia (Low Potassium Levels).

4. Patients may feel weary or weak due to fatigue.

5. Increasing Liver Enzymes: This could alter the results of liver function tests.

6. Gastrointestinal Problems: Common side effects include nausea, vomiting, and diarrhoea.

7. Muscle and joint pain: Some people may feel joint or muscle pain.

8. Hot Flashes: The Zelgor therapy may result in hot flashes or warm emotions.

9. Abiraterone Acetate can induce swelling in various body parts, or edoema.

10. Cardiac Disorders: On occasion, it may result in cardiac problems like heart failure.

11. Abiraterone Acetate has an effect on the adrenal glands, which can cause adrenal insufficiency.

During Zelgor therapy, patients should be closely observed by medical personnel. Any symptoms that warrant further investigation should be reported right away to the healthcare professional as the medication carries a potential for serious adverse effects. Making treatment choices should be discussed with oncologists or other medical professionals skilled in treating metastatic castration-resistant prostate cancer. During Zelgor treatment, regular monitoring of blood pressure and liver function is crucial.